In late 2025, a masked speaker appeared in a video shared across Chinese-language social media. He claimed to be an undercover activist familiar with criminal networks that traffic people into cyberfraud centers in Southeast Asia. The man described an elaborate and disturbing system hidden inside some of these compounds, involving forced pregnancies, controlled births, and the extraction of biological material from infants.
His allegations have not been independently verified. But because they intersect with real trafficking networks and a growing, often unregulated anti-aging industry in the region, the video drew widespread attention.
The video that sparked the controversy
The speaker said he had spent time inside compounds run by trafficking syndicates in Myanmar and Cambodia. Many of the women he encountered, he claimed, had been lured from nightlife or entertainment jobs through fraudulent recruitment schemes. Once inside, younger women were reportedly forced into sexual exploitation or used to entice online victims. Older women, he said, were typically assigned to staff the scam operations: typing, messaging, and managing fraudulent accounts.
According to him, this was only one layer of the exploitation. He said that some older women were also coerced into pregnancies through in vitro fertilization—carrying multiple embryos at once and giving birth under the control of the traffickers.
To understand the environment he described, it helps to look at how these trafficking networks function.
Success
You are now signed up for our newsletter
Success
Check your email to complete sign up
How trafficking networks operate in Southeast Asia
Across parts of Myanmar, Laos, and Cambodia, organized crime groups operate large fortified compounds used for online fraud. Reports from journalists, regional governments, and NGOs have documented the pattern: victims recruited under false pretenses, trafficked across borders, stripped of their passports, and forced into grueling cyber-scam labor.
Women are especially vulnerable. Criminal groups often prefer recruiting women from hospitality or nightlife jobs because they are easier to isolate socially and entice with false offers of overseas work. Inside the compounds, assignment to “roles” is determined by appearance and age: younger women into sex work or into roles involving online grooming, older women into scam operations or administrative tasks.
It was within this setting, the whistleblower said, that a far more alarming series of abuses took place behind closed doors.
Inside the alleged forced birth and infant harvesting system
According to the speaker, certain women, usually over the age of forty, were forcibly implanted with embryos using IVF. He claimed that multiple embryos were implanted at once so the women would carry twins or triplets. The births, he said, occurred under conditions controlled entirely by the traffickers, and the infants were taken from the mothers immediately.
He described a room filled with glass enclosures where the infants were kept. Staff members reportedly cleaned the enclosures, fed the infants, and monitored them but did not allow normal physical movement or interaction. The whistleblower claimed that the children were raised in isolation, handled only when necessary.
What he described next was the part that drew the most attention. Around six months of age, the infants were allegedly subjected to a procedure in which marrow or spinal fluid was extracted from along the spine. He said this fluid contained “growth factors” that were then refined into regenerative stem-cell products.
He alleged that each extraction could be processed into several vials of anti-aging injections — and that the same child could be used multiple times.
In vitro fertilization can produce multiple embryos at once. In legitimate medicine, this improves the chance of pregnancy. In criminal contexts, IVF could be misused to produce multiple births simultaneously, increasing the number of infants available for exploitation.
The laboratory at the center of the allegations
In the video, the whistleblower mentioned a facility he referred to as the Life Science Institute of Cambodia. He claimed the institute processed the biological materials into anti-aging treatments and marketed them to wealthy clients.
Archives of the institute’s Chinese-language website showed promotional materials for stem-cell therapies and “rejuvenation” injections. Some pages listed partnerships with hospitals in Hunan Province, though much of the content was later modified or removed.
Archived pages also identified several Chinese partners: Xiangya Hospital, Xiangya No. 2 Hospital, Xiangya No. 3 Hospital, Hunan Normal University, and the First and Second Affiliated Hospitals of Nanhua University. These facilities have longstanding links to influential political families inside China. Xiangya No. 2 Hospital, for example, is partly controlled by Guang Jiguang, the grandson of former premier Li Peng and a figure implicated in the infamous death of Chinese actor Yu Menglong. The Cambodian institute’s partnership claims placed it within a wider network of Chinese medical and business interests that already intersect with elite political circles.
Online researchers pointed out that the institute’s listed address matched that of Prince Group, a major Cambodian conglomerate led by businessman Chen Zhi, who has drawn scrutiny for his alleged ties to Chinese Communist Party (CCP) political interests.
The wealthy clients drawn to anti-aging therapies
The last part of the whistleblower’s account focused on who he believed purchased the treatments derived from the compounds. He said the buyers were not ordinary patients, but extremely wealthy figures in China — celebrities, high-net-worth businesspeople, and individuals connected to powerful Party families. According to him, a single vial sold for several million yuan, pricing it far beyond the reach of the general public and placing it firmly inside elite circles.
That demand, in his account, linked the compounds directly to China’s ruling class.
Several major hospitals in Hunan — including Xiangya Hospital, Xiangya No. 2, Xiangya No. 3, and the two affiliated hospitals of Nanhua University — operate under the influence of families tied to senior Chinese Communist Party officials. Xiangya No. 2 Hospital, for example, includes stakeholders connected to the family of former premier Li Peng, a key figure in post-Tiananmen politics and one of the most deeply entrenched networks inside the Party.
These hospitals are not just medical centers, but function as patronage platforms where political families shape leadership appointments, direct research budgets, and channel contracts to allied businesses. Their reach extends into pharmaceuticals, medical technology, and cross-border investments — giving Party elites influence over ventures that move between China and Southeast Asia.
When an overseas clinic claims partnerships with institutions like these, it is not simply accessing medical expertise, but connecting with hospital networks built to serve the CCP elite.
This combination — alleged demand from wealthy Chinese clients and direct ties to hospitals controlled by Party-connected families — pushed the story out of the realm of ordinary criminality. In the whistleblower’s account, the system relied on elite Chinese buyers and on medical networks shaped by political families, creating a pipeline that ran from Southeast Asian compounds to the upper reaches of China’s ruling class.
The whistleblower’s account sits at the intersection of two worlds that already exist: the trafficking compounds that dot parts of Southeast Asia, and an anti-aging market eager for treatments that move faster than regulation. His video added a darker layer to that landscape, describing a system built on coercion and the exploitation of the most vulnerable, sustained by the demand of China’s wealthy families and elite Communist Party circles.
Whatever the origins of his story, the environment he described is real enough to give it weight. People continue to disappear into these compounds, and many clinics promoting regenerative therapies operate with minimal oversight. In places where criminal networks control entire facilities and profit drives experimentation, the distance between what is possible and what is plausible can narrow quickly.
For now, the video remains one account from a region where much happens out of sight. But the conditions that allow such a story to take shape — criminal syndicates, weak regulation, and the presence of networks serving China’s politically connected elite — are firmly in place. And those who fall prey to these systems often have no way out.
